Search
Search Results
##search.searchResults.foundPlural##
-
HEMATOPOIETIC CELL TRANSPLANTATION FOR OLDER PATIENTS WITH MDS
2048PDF: 774HTML: 3118 -
CAR-T CELL THERAPY IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA CAR-T CELL and B-ALL
4359PDF: 3578HTML: 221 -
EPIDEMIOLOGY OF MALARIA IN THE STATE OF QATAR, 2008-2015
1993PDF: 1012HTML: 432 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1851PDF: 925HTML: 970Referring article: 754 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2426PDF: 1112HTML: 2173Untitled: 169 -
REGULATORY T-CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA
2353PDF: 1005HTML: 7629Untitled: 287Fig2: 189Fig3: 178Fig4: 187 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1248PDF: 606HTML: 2870ATRA induced Reactive Hemophagocytosis: A Case Report: 203 -
-
SYSTEMIC MASTOCYTOSIS: MULTIDISCIPLINARY APPROACH Systemic Mastocytosis
1588PDF: 1046HTML: 238 -
ASSOCIATION OF VDBP RS4701 VARIANT, BUT NOT VDR/RXR-? OVER-EXPRESSION WITH BONE MINERAL DENSITY IN PEDIATRIC ?-THALASSEMIA PATIENTS Vitamin D metabolic axis and BMD in ?-thalassemia
1278PDF: 740HTML: 212 -
THE Co-Occurrence of Jak2/Calr-Positive Myeloproliferative Disorder and Bcr-Abl-Positive Chronic Myelogenous Leukaemia Treated with Combination of Tyrosine Kinase Inhibitors and Ruxolitinib. Dual Myeloid Disorder Treated with Two Drug Association
1088PDF: 1172HTML: 98 -
LYMPHOCYTES IN PATIENTS WITH CHRONIC ACTIVE EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1 EXPRESSION AND A PREVAILING TH2 IMMUNE RESPONSE. EPSTEIN-BARR VIRUS INFECTION EXHIBITED ELEVATED PD-1/PD-L1
2844PDF: 1105HTML: 123 -
PROCALCITONIN AS A BIOMARKER OF BACTERIAL INFECTION IN SICKLE CELL VASO-OCCLUSIVE CRISIS.
2092PDF: 1061HTML: 15660COVER LETTER: 194 -
Guest Editor: Raffaella Origa IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION: TIME TO CHANGE THE PARADIGM. IRON TOXICITY AND HEMOPOIETIC CELL TRANSPLANTATION
1956PDF: 1228HTML: 250 -
TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA WITH AIDA BASED REGIMEN
3985PDF: 763HTML: 1855 -
Thalidomide treatment for thrombocytopenia secondary to hypersplenism in children with β-thalassemia major: a case series Thalidomide treatment for thrombocytopenia
902PDF: 744HTML: 123 -
CAR-T CELL THERAPY FOR T-CELL MALIGNANCIES CAR-T CELL FOR T-CELL MALIGNANCIES
2229PDF: 2063HTML: 199 -
DOWNREGULATION OF STEAROYL-COA DESATURASE 1 (SCD-1) PROMOTES RESISTANCE TO IMATINIB IN CHRONIC MYELOID LEUKEMIA Downregulation of Scd-1 in Chronic Myeloid Leukemia
1363PDF: 1247HTML: 463 -
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2161PDF: 501HTML: 153 -
Acute Panmyelosis with Myelofibrosis - A Rare Subtype of Acute Myeloid Leukemia
3190PDF: 978HTML: 3137flowcytometric result of peripheral blood sample: 186 -
RECURRENT/PERSISTENT PNEUMONIA AMONG CHILDREN IN UPPER EGYPT
2012PDF: 910HTML: 241Untitled: 234Untitled: 237cover letter: 179 -
A A RETROSPECTIVE LONG-TERM STUDY ON AGE AT MENARCHE AND MENSTRUAL CHARACTERISTICS IN 85 YOUNG WOMEN WITH TRANSFUSION-DEPENDENT Β-THALASSEMIA (TDT) BORN BETWEEN 1965 AND 1995 Long-Term Study on Age at Menarche and Menstrual Characteristics in patients with TDT
1551PDF: 511HTML: 181 -
PREVALENCE OF ß-THALASSEMIA MUTATIONS AMONG NORTHEASTERN IRANIAN POPULATION AND THEIR IMPACTS ON HEMATOLOGICAL INDICES AND APPLICATION OF PRENATAL DIAGNOSIS, A SEVEN-YEARS STUDY
2432PDF: 969HTML: 396Supplementary table 1: 228Some of the mutation detection samples: 218 -
-
FASTING PLASMA GLUCOSE LEVELS WITHIN THE HIGH NORMAL RANGE ARE ASSOCIATED WITH A SIGNIFICANTLY INCREASED RISK OF FUTURE DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β THALASSEMIA: A DECADE-LONG MULTICENTER RETROSPECTIVE ANALYSIS Higher normal fasting plasma glucose and glucose dysregulation in β- thalassemia
675PDF: 257Html: 33







